Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Imaging Agents Market by Type (Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders), By Application (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Imaging Agents Market by Type (Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders), By Application (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 195967 3300 Medical Devices & Consumables 377 233 Pages 4.9 (38)
                                          

The global imaging agents market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing number of patients with chronic diseases and rising demand for minimally invasive procedures. Oncology segment accounted for the largest share in the global imaging agents market in 2018, followed by cardiology, gastrointestinal disorders, neurology disorders and others (e.g., dermatology). Oncology segment is expected to continue its dominance throughout the forecast period due to increasing incidence rates of cancer globally and growing adoption of oncological treatments such as chemotherapy and radiotherapy. Cardiology segment is projected to grow at a CAGR of 6% during the forecast period due to increasing prevalence rates of cardiovascular diseases globally and growing adoption rate for minimally invasive procedures such as angioplasty or stenting procedures which require use of contrast agents. Gastrointestinal disorders are projected to grow at a CAGR higher than 7% during the forecast period due to rising incidence rates among people aged 65 years or older who are more susceptible towards gastrointestinal problems such as ulcers or colitis which require use of contrast agents for diagnosis purposes.

Some Of The Growth Factors Of This Market:

  1. The Imaging Agents market is driven by the increasing prevalence of chronic diseases, such as cancer and diabetes, which are leading to an increase in the number of imaging procedures.
  2. The Imaging Agents market is also driven by the increasing demand for minimally invasive procedures and diagnostic imaging devices.
  3. Increasing healthcare expenditure in emerging economies such as China and India will drive growth in the Imaging Agents market.
  4. Technological advancements in medical imaging equipment will also drive growth.

Industry Growth Insights published a new data on “Imaging Agents Market”. The research report is titled “Imaging Agents Market research by Types (Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders), By Applications (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers, Others), By Players/Companies Bayer Healthcare Pharmaceuticals, Bracco Diagnostics, Daiichi Sankyo, Eisai, Eli Lilly and Company, EUSA Pharma, GE Healthcare, Guerbet Group, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals, Shenzhen Xingjingwei, Beijing Chemical Reagent Research Institute, Lanxing Chemial Materials, Baoding Lucky Chemical”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Imaging Agents Market Research Report

By Type

Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders

By Application

Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers, Others

By Companies

Bayer Healthcare Pharmaceuticals, Bracco Diagnostics, Daiichi Sankyo, Eisai, Eli Lilly and Company, EUSA Pharma, GE Healthcare, Guerbet Group, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals, Shenzhen Xingjingwei, Beijing Chemical Reagent Research Institute, Lanxing Chemial Materials, Baoding Lucky Chemical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Imaging Agents Industry Outlook


Global Imaging Agents Market Report Segments:

The global Imaging Agents market is segmented on the basis of:

Types

Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic & imaging centers, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Bayer Healthcare Pharmaceuticals
  2. Bracco Diagnostics
  3. Daiichi Sankyo
  4. Eisai
  5. Eli Lilly and Company
  6. EUSA Pharma
  7. GE Healthcare
  8. Guerbet Group
  9. Lantheus Medical Imaging
  10. Mallinckrodt Pharmaceuticals
  11. Shenzhen Xingjingwei
  12. Beijing Chemical Reagent Research Institute
  13. Lanxing Chemial Materials
  14. Baoding Lucky Chemical

Global Imaging Agents Market Overview


Highlights of The Imaging Agents Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Oncology
    2. Cardiology
    3. Gastrointestinal Disorders
    4. Neurology Disorders
  1. By Application:

    1. Hospitals & Clinics
    2. Ambulatory Surgical Centers
    3. Diagnostic & imaging centers
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Imaging Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Imaging Agents Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Imaging agents are chemicals that can be used to create images of the body. These images may be used for medical purposes, such as diagnosing diseases or injuries, or for cosmetic purposes, such as improving the appearance of skin.

Some of the major companies in the imaging agents market are Bayer Healthcare Pharmaceuticals, Bracco Diagnostics, Daiichi Sankyo, Eisai, Eli Lilly and Company, EUSA Pharma, GE Healthcare, Guerbet Group, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals, Shenzhen Xingjingwei, Beijing Chemical Reagent Research Institute, Lanxing Chemial Materials, Baoding Lucky Chemical.

The imaging agents market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Imaging Agents Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Imaging Agents Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Imaging Agents Market - Supply Chain
   4.5. Global Imaging Agents Market Forecast
      4.5.1. Imaging Agents Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Imaging Agents Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Imaging Agents Market Absolute $ Opportunity

5. Global Imaging Agents Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Imaging Agents Market Size and Volume Forecast by Type
      5.3.1. Oncology
      5.3.2. Cardiology
      5.3.3. Gastrointestinal Disorders
      5.3.4. Neurology Disorders
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Imaging Agents Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Imaging Agents Market Size and Volume Forecast by Application
      6.3.1. Hospitals & Clinics
      6.3.2. Ambulatory Surgical Centers
      6.3.3. Diagnostic & imaging centers
      6.3.4. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Imaging Agents Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Imaging Agents Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Imaging Agents Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Imaging Agents Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Imaging Agents Demand Share Forecast, 2019-2026

9. North America Imaging Agents Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Imaging Agents Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Imaging Agents Market Size and Volume Forecast by Application
      9.4.1. Hospitals & Clinics
      9.4.2. Ambulatory Surgical Centers
      9.4.3. Diagnostic & imaging centers
      9.4.4. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Imaging Agents Market Size and Volume Forecast by Type
      9.7.1. Oncology
      9.7.2. Cardiology
      9.7.3. Gastrointestinal Disorders
      9.7.4. Neurology Disorders
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Imaging Agents Demand Share Forecast, 2019-2026

10. Latin America Imaging Agents Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Imaging Agents Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Imaging Agents Market Size and Volume Forecast by Application
      10.4.1. Hospitals & Clinics
      10.4.2. Ambulatory Surgical Centers
      10.4.3. Diagnostic & imaging centers
      10.4.4. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Imaging Agents Market Size and Volume Forecast by Type
      10.7.1. Oncology
      10.7.2. Cardiology
      10.7.3. Gastrointestinal Disorders
      10.7.4. Neurology Disorders
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Imaging Agents Demand Share Forecast, 2019-2026

11. Europe Imaging Agents Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Imaging Agents Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Imaging Agents Market Size and Volume Forecast by Application
      11.4.1. Hospitals & Clinics
      11.4.2. Ambulatory Surgical Centers
      11.4.3. Diagnostic & imaging centers
      11.4.4. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Imaging Agents Market Size and Volume Forecast by Type
      11.7.1. Oncology
      11.7.2. Cardiology
      11.7.3. Gastrointestinal Disorders
      11.7.4. Neurology Disorders
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
  11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Imaging Agents Demand Share, 2019-2026

12. Asia Pacific Imaging Agents Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Imaging Agents Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Imaging Agents Market Size and Volume Forecast by Application
      12.4.1. Hospitals & Clinics
      12.4.2. Ambulatory Surgical Centers
      12.4.3. Diagnostic & imaging centers
      12.4.4. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Imaging Agents Market Size and Volume Forecast by Type
      12.7.1. Oncology
      12.7.2. Cardiology
      12.7.3. Gastrointestinal Disorders
      12.7.4. Neurology Disorders
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Imaging Agents Demand Share, 2019-2026

13. Middle East & Africa Imaging Agents Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Imaging Agents Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Imaging Agents Market Size and Volume Forecast by Application
      13.4.1. Hospitals & Clinics
      13.4.2. Ambulatory Surgical Centers
      13.4.3. Diagnostic & imaging centers
      13.4.4. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Imaging Agents Market Size and Volume Forecast by Type
      13.7.1. Oncology
      13.7.2. Cardiology
      13.7.3. Gastrointestinal Disorders
      13.7.4. Neurology Disorders
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Imaging Agents Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Imaging Agents Market: Market Share Analysis
   14.2. Imaging Agents Distributors and Customers
   14.3. Imaging Agents Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Bayer Healthcare Pharmaceuticals
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Bracco Diagnostics
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Daiichi Sankyo
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Eisai
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Eli Lilly and Company
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. EUSA Pharma
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. GE Healthcare
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Guerbet Group
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Lantheus Medical Imaging
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Mallinckrodt Pharmaceuticals
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Shenzhen Xingjingwei
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Beijing Chemical Reagent Research Institute
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Lanxing Chemial Materials
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Baoding Lucky Chemical
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us